Crown Bioscience and NEXT Oncology Cement Partnership Extension

Crown Bioscience announced the extension of its partnership with NEXT Oncology to leverage Crown Bioscience’s extensive experience in developing clinically relevant cancer organoid and patient-derived xenograft models, together with NEXT Oncology’s global clinical network and Phase I clinical trials expertise.